PFM
ONC

Privium Fund Management’s BeOne Medicines Ltd ONC Stock Holding History

Privium Fund Management’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-15,000
Closed -$2.83M – 290
2022
Q1 		$2.83M Buy
+15,000
New +$3.19M 0.63% 33

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return

Privium Fund Management's ONC Position: Q2 2022 in Review

Privium Fund Management sold out of BeOne Medicines Ltd (ONC) in Q2 2022, closing a stake of 15,000 shares — an estimated $2.83M sold.

Privium Fund Management first reported a position in ONC in Q1 2022 and held it in 1 quarter. The position peaked at $2.83M in Q1 2022. 235 funds tracked by Wall St. Rank hold ONC as of Q2 2022.

  • Privium Fund Management reported no remaining BeOne Medicines Ltd position as of Q2 2022 after selling out during the quarter.
  • Privium Fund Management sold 15,000 BeOne Medicines Ltd shares in Q2 2022, an estimated $2.83M.
  • Privium Fund Management first reported a position in BeOne Medicines Ltd in Q1 2022 and held it in 1 quarter.
  • Privium Fund Management's BeOne Medicines Ltd position peaked at $2.83M in Q1 2022.
  • 235 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2022.

Based on Privium Fund Management's 13F filing for Q2 2022, filed 28 Jul 2022.